Stocktoria

HCA Healthcare, Inc. HCA

NYSE · stock · Services-General Medical & Surgical Hospitals, NEC · website · IPO 2010-12-28 · LEI

HCA Healthcare, Inc. (HCA) earns a Piotroski F-score of 6/9 (mixed financial health). It pays a dividend yielding 0.78% (safety: safe). FY2025 revenue was $75.6B at a 9.0% net margin.

Chart by TradingView
57/100
Stocktoria Quality Score · grade C
6/9
Piotroski F — financial health
Altman Z″ — distress risk
0.8%
Dividend yield 5y avg · safe · Dividend payout 10.0%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
6 6 6 6 6 6 4 6 6 6 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$414.59 as of 2026-08-01 · +2.6% 1y
$378.54$529.7052-wk
Market cap USD$86.9B
P / E12.8×
Dividend yield 5y avg0.8%
Net margin 5y avg9.3%
Return on equity 5y avg467.2%
Beta1.11
Employees230,000

Analyst price target

$454.57 +9.6% vs last
consensus: buy · 21 analysts
target range $380.00 – $579.00 · median $450.00
1 strong buy · 13 buy · 10 hold · 1 sell
Recent analyst actions
DateFirmRating
2026-08-03Wells FargoEqual-Weight (main)
2026-07-28Goldman SachsBuy (main)
2026-07-28MizuhoOutperform (main)
2026-07-27UBSBuy (main)
2026-07-27Morgan StanleyUnderweight (main)
2026-07-27RBC CapitalOutperform (reit)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$32.12
Forward P / E12.9×
Next ex-dividend2026-09-16

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Smart money · insiders, last 12 months

Insiders net sold -$903,537 on the open market · 1 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Services · percentile among 982 companies

Piotroski Fstronger than 76%
Net marginstronger than 76%
Revenue growthstronger than 49%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 6/9 tests passed

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
HCAHCA Healthcare, Inc.6/912.8+7.1%
THCTENET HEALTHCARE CORP3/92.33+3.1%
UHSUNIVERSAL HEALTH SERVICES INC7/93.555.9+9.7%
CYHCOMMUNITY HEALTH SYSTEMS INC8/90.280.9-1.2%
ARDTArdent Health, Inc.5/910.3+6%
SGRYSurgery Partners, Inc.5/91.09+6.2%
GOOGAlphabet Inc.5/96.7931.1+15.1%

All Services companies →

About HCA Healthcare, Inc.

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

FAQ

Is HCA financially healthy?

HCA Healthcare, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak).

Does HCA pay a dividend, and is it safe?

Yes. HCA Healthcare, Inc. pays a dividend yielding about 0.78% with a 10.0% payout ratio, rated “safe” for safety.

How profitable is HCA?

In FY2025, HCA Healthcare, Inc. had a net margin of 9.0%.

Is HCA overvalued or undervalued?

HCA Healthcare, Inc. trades at about 14.6× trailing earnings — near its 10-year norm (10-year range 11.0×–17.2×, median 14.9×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for HCA?

The average Wall-Street price target for HCA Healthcare, Inc. is $454.57, about 9.6% above the recent price, from 21 analysts (consensus: buy).

Is HCA a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on HCA Healthcare, Inc.: a Piotroski F-score of 6/9, a P/E of about 12.8×, a dividend yield of 0.78%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.